All In MedTech

Device Trial Radar · NCT02459054

Syncardia 50cc TAH-t as a Bridge to Transplant

SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant

Last checked: Nov 20, 2026Latest source record: Aug 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

16

Actual

Start

Oct 2015

Primary completion

Jul 29, 2020

Study completion Jul 29, 2020

Sponsor

Lead sponsor
SynCardia Systems. LLCNot on our public-company list
Sponsor type
Industry
First posted
Jun 1, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 10 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to evaluate whether the 50cc TAH-t can safely support, and provide probable benefit to, transplant-eligible pediatric patients (aged 10 - 18 years) and can safely and effectively support transplant-eligible adult patients (aged 19 - 75 years) at imminent risk of death from biventricular failure without experiencing permanent disabling, stroke-related deficits. The study will be conducted as a three-arm trial of the 50cc temporary Total Artificial Heart (TAH-t) as a bridge to transplant: * The Primary Pediatric Arm of the trial will evaluate the safety and probable benefit of the 50cc TAH-t for transplant-eligible patients 10 through 18 years of age. * The Primary Adult Arm of the trial will evaluate the safety and efficacy of the 50cc TAH-t for transplant-eligible patients 19 through 75 years of age. * The Secondary Arm will capture pediatric and adult subjects who did not meet enrollment criteria for a Primary Arm, but meet the less restrictive Secondary Arm enrollment criteria, in order to further characterize the use of the device.

Conditions

  • Heart Failure, Right-Sided
  • Cardiac Failure
  • Heart Failure, Left-Sided

Interventions

  • SynCardia 50cc temporary Total Artificial Heart (TAH-t)Device

    Replacement of both ventricles and all four valves with the investigational device as a bridge to transplantation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Probable Benefit (for Pediatric Arm); Efficacy (for Adult Arm)Time frame: 6 months

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University Medical Center

    Tucson, Arizona

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • University of California Los Angeles

    Los Angeles, California

23 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.